Abstract
Every year about 15,000 people in Japan are diagnosed with cervical cancer, and there are approximately 3,500 deaths. Cervical cancer in young adults is still increasing.
There are a number of issues facing cervical cancer screening in Japan. Firstly, the attendance rate for cervical cancer screening is very low. Secondly, although the Bethesda System is gradually spreading in Japan, conventional cytology is still the major approach, and liquid based cytology is not popular. Thirdly, HPV and Pap co-test has not been introduced as a method of mass public screening. Fourthly, without scientific discussion, the Japanese Government abruptly ceased to recomend HPV vaccination in June 2013.
Cervical cancer is already a preventable disease. The Japanese Government must pay attention to WHO and FIGO specialists.
